VCRE
Vicore Pharma Holding AB
9.40$
-0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +47.3% | +140.2% | +1.9% | |
| – | +83.7% | +141.2% | +1.8% | |
| – | +29.9% | +246.5% | -50.0% | |
| – | -96.7% | – | – | |
| – | -13.2% | +56.1% | +85.9% | |
| – | -11.8% | +60.4% | +80.3% | |
| – | -23.7% | +67.3% | +31.7% | |
| – | +57.5% | +148.0% | -3.0% | |
| – | – | – | – | |
| – | +36.5% | +104.3% | +20.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.